UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

Breast (Edinburgh), 2022-10, Vol.65, p.164-171

2022

Volltextzugriff (PDF)

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4779-4734

2004

Volltextzugriff (PDF)

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

European journal of cancer (1990), 2021-01, Vol.142, p.18-28

2021

Volltextzugriff (PDF)

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

The oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.e723-e730

2022

Volltextzugriff (PDF)

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001361

2020

Volltextzugriff (PDF)

Response to chemotherapy of a radiation-induced glioblastoma multiforme

Journal of neuro-oncology, 2006-05, Vol.78 (1), p.55-57

2006

Volltextzugriff (PDF)

Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach

Critical reviews in oncology/hematology, 2022-12, Vol.180, p.103848, Article 103848

2022

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Clinical cancer research, 2023-07, Vol.29 (14), p.2714-2724

2023

Volltextzugriff (PDF)

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.865-874

2022

Volltextzugriff (PDF)

T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner

Journal of leukocyte biology, 2004-05, Vol.75 (5), p.798-804

2004

Volltextzugriff (PDF)

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

Journal of translational medicine, 2021-06, Vol.19 (1), p.270-270, Article 270

2021

Volltextzugriff (PDF)

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab

Journal of clinical medicine, 2021-03, Vol.10 (5), p.1005

2021

Volltextzugriff (PDF)

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

Blood, 2004-07, Vol.104 (2), p.502-508

2004

Volltextzugriff (PDF)

Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas

Journal of neuro-oncology, 2008-07, Vol.88 (3), p.293-298

2008

Volltextzugriff (PDF)

A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro‐Oncologia

Cancer, 2005-07, Vol.104 (1), p.143-148

2005

Volltextzugriff (PDF)

The role of prognostic factors in metastatic renal cell carcinoma (mRCC) treated with targeted therapies (TT): Data from an Italian retrospective multicentric study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e15512-e15512

2013

Volltextzugriff (PDF)

CYP2D6 pharmacogenetic testing: Beliefs and psychological effects in breast cancer patients treated with adjuvant tamoxifen (T)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20541-e20541

2013

Volltextzugriff (PDF)

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

Neuro-oncology (Charlottesville, Va.), 2006-07, Vol.8 (3), p.253-260

2006

Volltextzugriff (PDF)

Dextromethorphan phenotyping as a test for prediction of tamoxifen (TAM) activation in breast cancer patients receiving adjuvant hormone therapy

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13019-e13019

2012

Volltextzugriff (PDF)

Current clinical management of gastrointestinal stromal tumors

Expert review of anticancer therapy, 2004-08, Vol.4 (4), p.595-605

2004

Volltextzugriff (PDF)

Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes

British journal of haematology, 2003-03, Vol.120 (5), p.765-773

2003

Volltextzugriff (PDF)

Chemotherapy in brain metastases of lung and breast cancer

Therapy, 2004-09, Vol.1 (1), p.101-110

2004

Volltextzugriff (PDF)

Top-Down MALDI-In-Source Decay-FTICR Mass Spectrometry of Isotopically Resolved Proteins

Analytical chemistry (Washington), 2015-03, Vol.87 (6), p.3429-3437

2015

Volltextzugriff (PDF)

Chemical Synthesis and Immunological Evaluation of Fragments of the Multiantennary Group-Specific Polysaccharide of Group B Streptococcus

JACS Au, 2022-07, Vol.2 (7), p.1724-1735

2022

Volltextzugriff (PDF)

In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass Spectrometry

Journal of the American Society for Mass Spectrometry, 2016-01, Vol.27 (1), p.50-58

2016

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)
Bücher
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Response to chemotherapy of a radiation-induced glioblastoma multiforme

Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas

A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro‐Oncologia

The role of prognostic factors in metastatic renal cell carcinoma (mRCC) treated with targeted therapies (TT): Data from an Italian retrospective multicentric study

CYP2D6 pharmacogenetic testing: Beliefs and psychological effects in breast cancer patients treated with adjuvant tamoxifen (T)

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

Dextromethorphan phenotyping as a test for prediction of tamoxifen (TAM) activation in breast cancer patients receiving adjuvant hormone therapy

Current clinical management of gastrointestinal stromal tumors

Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes

Chemotherapy in brain metastases of lung and breast cancer

Top-Down MALDI-In-Source Decay-FTICR Mass Spectrometry of Isotopically Resolved Proteins

Chemical Synthesis and Immunological Evaluation of Fragments of the Multiantennary Group-Specific Polysaccharide of Group B Streptococcus

In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass Spectrometry

Suchergebnisse filtern